FDA’s draft guidance promotes diversity in clinical trials, ASCO says in new comments

Which cancers receive the least funding & why?

ASCO presentations illustrate sexism & bias among women in oncology

Study confirms disparities in triple-negative breast cancer diagnoses

2019 All.Can International Patient Survey

Individual- & county-level determinants of high breast cancer incidence rates

Surgery is linked to higher survival rates among patients with HER2+ stage IV breast cancer

Fewer women with ovarian, breast cancer undergo genetic testing than expected

Cancer geneticists tackle troubling ethnic bias in studies